Skip to Navigation
Skip to Main Content
Skip to Related Content

Advertisement

U.S. Markets open in 9 hrs 29 mins

S&P Futures
5,909.25
+3.25(+0.06%)
Dow Futures
43,549.00
+31.00(+0.07%)
Nasdaq Futures
20,487.50
+4.00(+0.02%)
Russell 2000 Futures
2,294.50
+3.30(+0.14%)
Crude Oil
69.53
+0.31(+0.45%)
Gold
2,746.40
+16.40(+0.60%)

Pharmala Biotech Holdings Inc. (MDMA.CN)

Canadian Sec - Canadian Sec Real Time Price. Currency in CAD

Follow

0.1450

+0.0050

(+3.57%)

At close: 03:38PM EDT

Currency in CAD

Valuation Measures⁴

Market Cap (intraday)	13.91M
Enterprise Value	13.87M
Trailing P/E	N/A
Forward P/E	N/A
PEG Ratio (5 yr expected)	N/A
Price/Sales (ttm)	9.77
Price/Book (mrq)	10.36
Enterprise Value/Revenue	10.82
Enterprise Value/EBITDA	-11.51

Trading Information

Stock Price History

Beta (5Y Monthly)	N/A
52-Week Change ³	N/A
S&P500 52-Week Change ³	N/A
52 Week High ³	0.3500
52 Week Low ³	0.0650
50-Day Moving Average ³	0.0917
200-Day Moving Average ³	0.1527

Share Statistics

Avg Vol (3 month) ³	216.06k
Avg Vol (10 day) ³	334.25k
Shares Outstanding ⁵	95.94M
Implied Shares Outstanding ⁶	N/A
Float ⁸	N/A
% Held by Insiders ¹	5.34%
% Held by Institutions ¹	0.00%
Shares Short (Sep 15, 2023) ⁴	52.08k
Short Ratio (Sep 15, 2023) ⁴	0.14
Short % of Float (Sep 15, 2023) ⁴	N/A
Short % of Shares Outstanding (Sep 15, 2023) ⁴	0.06%
Shares Short (prior month Aug 15, 2023) ⁴	21.32k

Dividends & Splits

Forward Annual Dividend Rate ⁴	N/A
Forward Annual Dividend Yield ⁴	N/A
Trailing Annual Dividend Rate ³	0.00
Trailing Annual Dividend Yield ³	0.00%
5 Year Average Dividend Yield ⁴	N/A
Payout Ratio ⁴	0.00%
Dividend Date ³	N/A
Ex-Dividend Date ⁴	N/A
Last Split Factor ²	N/A
Last Split Date ³	N/A

Financial Highlights

Fiscal Year

Fiscal Year Ends	N/A
Most Recent Quarter (mrq)	N/A

Profitability

Profit Margin	0.00%
Operating Margin (ttm)	0.00%

Management Effectiveness

Return on Assets (ttm)	N/A
Return on Equity (ttm)	N/A

Income Statement

Revenue (ttm)	N/A
Revenue Per Share (ttm)	N/A
Quarterly Revenue Growth (yoy)	N/A
Gross Profit (ttm)	N/A
EBITDA	N/A
Net Income Avi to Common (ttm)	N/A
Diluted EPS (ttm)	-0.0100
Quarterly Earnings Growth (yoy)	N/A

Balance Sheet

Total Cash (mrq)	N/A
Total Cash Per Share (mrq)	N/A
Total Debt (mrq)	N/A
Total Debt/Equity (mrq)	N/A
Current Ratio (mrq)	N/A
Book Value Per Share (mrq)	N/A

Cash Flow Statement

Operating Cash Flow (ttm)	N/A
Levered Free Cash Flow (ttm)	N/A